Kvashnin, Y.A.; Slepukhin, P.A.; Gazizov, D.A.; Zhilina, E.F.; Rusinov, G.L.; Verbitskiy, E.V.; Charushin, V.N.
(E)-2-(6-(4′-(Diphenylamino)-[1,1′-biphenyl]-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazin-5(4H)-ylidene)-2-(6-(4′-(diphenylamino)-[1,1′-biphenyl]-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl)acetonitrile. Molbank 2023, 2023, M1714.
https://doi.org/10.3390/M1714
AMA Style
Kvashnin YA, Slepukhin PA, Gazizov DA, Zhilina EF, Rusinov GL, Verbitskiy EV, Charushin VN.
(E)-2-(6-(4′-(Diphenylamino)-[1,1′-biphenyl]-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazin-5(4H)-ylidene)-2-(6-(4′-(diphenylamino)-[1,1′-biphenyl]-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl)acetonitrile. Molbank. 2023; 2023(3):M1714.
https://doi.org/10.3390/M1714
Chicago/Turabian Style
Kvashnin, Yuriy A., Pavel A. Slepukhin, Denis A. Gazizov, Ekaterina F. Zhilina, Gennady L. Rusinov, Egor V. Verbitskiy, and Valery N. Charushin.
2023. "(E)-2-(6-(4′-(Diphenylamino)-[1,1′-biphenyl]-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazin-5(4H)-ylidene)-2-(6-(4′-(diphenylamino)-[1,1′-biphenyl]-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl)acetonitrile" Molbank 2023, no. 3: M1714.
https://doi.org/10.3390/M1714
APA Style
Kvashnin, Y. A., Slepukhin, P. A., Gazizov, D. A., Zhilina, E. F., Rusinov, G. L., Verbitskiy, E. V., & Charushin, V. N.
(2023). (E)-2-(6-(4′-(Diphenylamino)-[1,1′-biphenyl]-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazin-5(4H)-ylidene)-2-(6-(4′-(diphenylamino)-[1,1′-biphenyl]-2-yl)-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl)acetonitrile. Molbank, 2023(3), M1714.
https://doi.org/10.3390/M1714
